Related Experiment Videos
Proliferating dendritic cell progenitors in human blood
The Journal of Experimental Medicine
|July 1, 1994
Summary
Researchers found a way to generate large numbers of dendritic cells (DCs) from adult blood. By adding specific cytokines, they could mobilize DC progenitors, paving the way for clinical applications in immunity and cancer therapy.
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- CD34+ cells in cord blood and marrow can generate dendritic cells (DCs).
- Adult blood has rare CD34+ cells, making DC progenitor identification challenging.
- Previous studies identified proliferating aggregates of DC progenitors in mice.
Purpose of the Study:
- To systematically search for dendritic cell (DC) progenitors in various blood contexts.
- To determine if adult blood can serve as a source for large numbers of immunostimulatory antigen-presenting cells.
- To optimize conditions for generating DCs from blood for clinical studies.
Main Methods:
- Searched for proliferating aggregates of DC progenitors in cord blood and adult blood.
- Used specific cytokines like granulocyte/macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor (TNF), and interleukin 4 (IL-4).
- Depleted erythroid progenitors and suppressed monocyte development to enhance DC generation.
Main Results:
- In cord blood, GM-CSF and TNF induced DC aggregates and progeny after erythroid progenitor depletion.
- In adult blood from patients receiving CSFs, GM-CSF and TNF generated DCs from HLA-DR negative precursors.
- In healthy adult blood, IL-4 addition with GM-CSF produced large DC aggregates and 3-8 million potent immunostimulatory DCs per 40ml within 5-7 days.
Conclusions:
- Large numbers of dendritic cells (DCs) can be mobilized from blood progenitors using specific cytokines.
- This method provides a viable source of DCs for future research on their receptors and therapeutic applications.
- Generated DCs are potent stimulators of T cells, suggesting potential for T cell-mediated resistance to viruses and tumors.